tm logo
Trademark Search
Biomea Fusion Logo - CIRCULAR PARALLEL LINES WITH DOT DESIGN
Biomea Fusion Logo - CIRCULAR PARALLEL LINES WITH DOT DESIGN
FORMALIZED

on 27 Nov 2024

Last Applicant/ Owned by

Biomea Fusion, Inc.

726 Main StreetRedwood City, CA 94063

US

Serial Number

2115585 filed on 21st Jun 2021

Correspondent Address

180 Kent StreetSuite 1900Ottawa

ONTARIO

CA

K1P0B6

Biomea Fusion Logo - CIRCULAR PARALLEL LINES WITH DOT DESIGN

Vienna Information


1 . 13 . 1

Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cells, images of bacteria or viruses, DNA helixesSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales, images de bactéries ou de virus, hélices d'ADN

26 . 1 . 1

CirclesCercles

26 . 1 . 5

More than two circles or ellipses, inside one another, spiralsPlus de deux cercles ou ellipses, les uns dans les autres, spirales

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

Trademark usage description

chemotherapeutics; adjuvants for medical purposes; anti-cancer preparations; anti-sarcoma preparations; cellular function activating agents for medica Read More

Classification Information


Class [005]
Chemotherapeutics; Adjuvants for medical purposes; Anti-cancer preparations; Anti-sarcoma preparations; Cellular function activating agents for medical purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer and metabolic diseases; Cytostatics for pharmaceutical purposes; Diagnostic preparations for medical purposes; Medical preparations for the treatment of cancer and metabolic diseases; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal preparations for cancer and metabolic diseases; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the prevention of cancer and metabolic diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer and metabolic diseases; Pharmaceutical preparations for the treatment and prevention of cancer and metabolic diseases; Pharmaceutical preparations for cancer and metabolic diseases; Pharmaceutical preparations, namely, elixirs for the treatment of cancer and metabolic diseases; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer and metabolic diseases; Tumor suppressing agents; Medicinal infusions for treating cancer and metabolic diseases; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents


Classification kind code

11

Class [042]
Biotechnology research; Development of new technology for others in the field of cancer and metabolic diseases; Development of pharmaceutical preparations and medicines; Medical and scientific research in the field of cancer treatment and diagnosis; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical research and scientific research information in the field of oncology via the Internet; Providing medical testing services and information in the field of cancer research and disease classification; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and metabolic diseases; Testing of pharmaceuticals; Medical research services; Pharmaceutical research services; Research and development of vaccines and medicines


Classification kind code

11

Class [044]
Providing a web site featuring medical information; Providing a website featuring information in the field of the diagnosis and treatment of cancer and metabolic diseases


Classification kind code

11

Mark Details


Serial Number

2115585

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 27th Nov 2024
Search Recorded
Submitted for opposition 20
on 27th Nov 2024
Examiner's First Report
Submitted for opposition 287
on 12th May 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 21st Jun 2021
Filed
Submitted for opposition 1
on 21st Jun 2021
Created
Submitted for opposition 31
on 21st Jun 2021
Formalized